Dutch Visitors Programme to the BIO 2018Friday, April 13, 2018
Meet relevant partners at the BIO and the companies we visit, like Research Institutes, Incubators and Accelerators, Innovation Hubs and Pharmaceutical Companies. Start-ups joining this mission will receive a substantial discount of € 1.500,- through the SIB Voucher (conditions apply). The Dutch Visitors Programme is open to all Dutch Life Sciences & Health organisations in the Biotechnology & Pharmaceuticals sector.
New England Journal of Medicine Published Open-label Study Showing Brineura® (cerliponase alfa) Reduced the Rate of Clinical Decline of Children with CLN2 Disease, a Form of Batten Disease
ISA Pharmaceuticals’ ISA101 Studied in Phase II Oropharyngeal Cancer Combination Trial at MD Anderson Cancer Center
Gilead and Galapagos announce results with filgotinib in the phase 2 equator study in psoriatic arthritis and progression into phase 3 for the selection study in ulcerative colitis